News

A family’s petition to make Spinraza – the first treatment for SMA – available for people with the condition has received more than 130,000 signatures.

Tesco has committed to building Changing Places toilets in selected stores, we can announce today.

Muscular Dystrophy UK has sent a written evidence submission to the House of Commons Science and Technology Committee’s inquiry on the preparations for a no-deal Brexit in relati

The Muscular Dystrophy Town and Gown 10k run is a hugely successful run which now needs your vote to win at the Running Awards 2019.

A phase 2 clinical trial has shown that zilucoplan can reduce the severity of generalised myasthenia gravis (MG).

Muscular Dystrophy UK’s Trailblazers worked with Heidi Allen MP, Chair of the Young Disabled Peron’s APPG, to submit written questions to the Secretary of State for Transport.

Catabasis has released an update on its PolarisDMD trial. This is a global phase 3 trial testing edasalonexent (CAT-1004) in boys with Duchenne muscular dystrophy.

Letter submitted to Health Minister

The Government has released its long term plan for improving NHS care in England over the next ten years, with an extra £20.5bn allocated to the NHS budget.

Wave Lifesciences' next Duchenne trial has been accepted onto a new FDA programme to advance and promote innovative trial designs.